Articles tagged "Liver transplantation"

2016 American Transplant Congress
Metabolomic Profiles of Hepatocellular Carcinoma and Cirrhotic Patients Before and After Transplantation.
C. Desai,¹ R. Varghese,² S. Robertazzi,¹ C. Di Poto,² A. Ferrarini,² C. Tu,² R. Girlanda,¹ K. Khan,¹ T. Fishbein,¹ H. Ressom.²
¹Medstar Georgetown Transplant institute, Washington DC; ²Department of Oncology, Lombardi Comprehensive Cancer Center, Washington DC.
Metabolomics offers the opportunity to characterize complex diseases like hepatocellular carcinoma (HCC) through a systematic evaluation of thousands of metabolites in human liver tissues and…
2016 American Transplant Congress
Assessment of Transplant Health Literacy of Liver Transplant Candidates and Their Caregivers.
Y. Bababekov,¹ Z. Fong,^1,2 J. Adler,¹ H. Yeh,¹ D. Chang,^1,2 J. Pomposelli.³
¹Surgery, Massachusetts General Hospital/Harvard Medical School, Boston, MA; ²Codman Center for Clinical Effectivness in Surgery, Massachusetts General Hospital/Harvard Medical School, Boston, MA; ³Transplantation, Lahey Hospital and Medical Center, Burlington, MA.
Purpose: All transplant programs provide education sessions and instructional material to their patients to improve health literacy. However, their efficacy is unknown. We piloted a…
2016 American Transplant Congress
Trends in Liver Transplant Rates and Waitlist Survival.
M. Bowring, A. Massie, X. Luo, L. Kucirka, E. Chow, A. Cameron, D. Segev.
JHU, Baltimore.
Long term changes in access to deceased-donor liver transplantation(DDLT) due to persistent growth of the waitlist, stagnant organ availability, and intermittent allocation policy changes have…
2016 American Transplant Congress
Risk Factors for Short and Long Term Mortality in High MELD Recipients.
A. Bertacco,^1,2 M. Rodriguez-Davalos,¹ M. Schilsky,³ P. Yoo,¹ S. Kulkarni,¹ B. Fortune,³ A. Liapakis,³ S. Emre,¹ D. Mulligan.¹
¹Surgery, Yale University, New Haven; ²Dipartimento di Scienze Chirurgiche Oncologiche e Gastroenterologiche - DiSCOG, Padova University, Padova, Italy; ³Yale New Haven Transplant Center, Yale University, New Haven.
The model for end-stage disease (MELD) score is used to stratify candidates for liver transplant (LT) based on objective measures. Since June 2013 with changes…
2016 American Transplant Congress
Telemedicine to Reduce Readmissions Post Liver Transplant: Compliance and Feasibility Results.
T. Kaiser,¹ P. Kimmel,² S. Osborn,² S. Diersing,² B. Boswell,² J. Huff,² J. Garrett,¹ N. Anwar,¹ S. Shah.¹
¹Medicine, University of Cincinnati, Cincinnati, OH; ²Transplant, University of Cincinnati Medical Center, Cincinnati, OH.
Telemedicine (TM) was added to our care model as a mechanism to reduce readmissions post liver transplant (LTx). Establishing a TM home allows for remote…
2016 American Transplant Congress
Transcatheter Aortic Valve Replacement (TAVR) for Severe Aortic Stenosis as a Bridge to Liver Transplantation.
R. Syed, P. Cox-Alomar, H. Bohorquez, G. Therapondos, N. Girgrah, S. Joshi, G. Tyson, T. Reichman, I. Carmody, G. Loss, A. Cohen, D. Bruce, E. Ahmed, J. Seal, P. Parrino, S. Ramee, N. Bzowej.
Ochsner Medical Center, New Orleans, LA.
Background: Historically, severe symptomatic aortic stenosis (AS) has been corrected surgically with aortic valve replacement. In patients with end stage liver disease (ESLD), cardiac surgery…
2016 American Transplant Congress
Association of Smoking Habits with Comorbidity 15 Years After Liver Transplantation.
S. Pischke,³ M. Lege,¹ L. Fischer,² U. Herden,² A. Lohse,³ B. Nashan,² M. Sterneck.¹
¹University Transplant Center, University Hospital Hamburg Eppendorf, Hamburg, Germany; ²Department of Hepatobiliary Surgery and Transplantation, University Hospital Hamburg Eppendorf, Hamburg, Germany; ³Department of Medicine, University Hospital Hamburg Eppendorf, Hamburg, Germany.
Background and aimsThe survival rate of liver transplant (OLT) recipients has strongly improved over the last years. Here we investigate the association between long term…
2016 American Transplant Congress
Conversion from Tacrolimus (TAC) to Sirolimus (SLR)-Based Immunosuppression in Pediatric Patients Who Underwent Liver Transplantation for Unresectable Hepatoblastoma – 2 Year Follow-Up.
R. Hendrickson,¹ W. Andrews,¹ M. Davis,¹ R. Cisneros,¹ R. Fischer,² J. Daniel.²
¹Pediatric/Transplant Surgery, Children's Mercy Hospitals and Clinics, Kansas City, MO; ²Hepatology, Children's Mercy Hospitals and Clinics, Kansas City, MO.
Introduction: The appropriate use of Sirolimus (SRL) immunosuppression in pediatric liver transplantation has yet to be clearly defined. Even though Tacrolimus (TAC) is commonly used…
2016 American Transplant Congress
Long Term Outcome of De-Novo Autoimmune Hepatitis in Pediatric Recipients of Liver Transplantation.
Y. Avitzur,¹ P. McKiernan,² M. Martinez,³ S. Lobritto,³ D. Kelly,² V. Ng,¹ E. Alonso,⁴ U. Ekong.⁵
¹Hospital for Sick Children, Toronto, Canada; ²Birmingham Children's Hospital, Birmingham, United Kingdom; ³Morgan Stanley Children's Hospital, New York; ⁴Lurie Children's Hospital, Chicago; ⁵Yale New Haven Children's Hospital, New Haven.
Background: De-novo autoimmune hepatitis (DAIH) is a chronic immune mediated graft disorder seen following liver transplantation (LT). The long-term course and outcome of DAIH is…
2016 American Transplant Congress
Acute Kidney Injury and Chronic Kidney Disease in Donation After Circulatory Death Liver Transplantation: UK Single Centre Study.
I. Umbro,^1,2 F. Tinti,^1,2 F. Evison,³ A. Sharif,⁴ B. Gunson,⁵ A. Mitterhofer,² J. Ferguson,¹ P. Muiesan.¹
¹The Liver Unit, Queen Elizabeth Hospital, Birmingham, United Kingdom; ²Nephrology and Dialysis Unit, Sapienza University of Rome, Rome, Italy; ³Department of Health Informatics, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom; ⁴Department of Nephrology and Transplantation, Queen Elizabeth Hospital, Birmingham, United Kingdom; ⁵NIHR Birmingham Liver Biomedical Research Unit and Centre for Liver Research, University of Birmingham, Birmingham, United Kingdom.
Aim of the study is to assess the incidence of acute kidney injury (AKI) and chronic kidney disease (CKD) after liver transplantation (LT) in DCD…